PrimeEnergy (PNRG) Reaches $66.84 52-Week High; Cardiovascular Systems (CSII) Shorts Down By 3.56%

April 17, 2018 - By Adrian Erickson

Cardiovascular Systems Inc (NASDAQ:CSII) had a decrease of 3.56% in short interest. CSII’s SI was 1.14M shares in April as released by FINRA. Its down 3.56% from 1.18M shares previously. With 212,400 avg volume, 5 days are for Cardiovascular Systems Inc (NASDAQ:CSII)’s short sellers to cover CSII’s short positions. The SI to Cardiovascular Systems Inc’s float is 3.45%. The stock increased 1.59% or $0.36 during the last trading session, reaching $23.05. About 44,782 shares traded. Cardiovascular Systems, Inc. (NASDAQ:CSII) has declined 21.67% since April 17, 2017 and is downtrending. It has underperformed by 33.22% the S&P500.

The stock of PrimeEnergy Corporation (NASDAQ:PNRG) hit a new 52-week high and has $70.18 target or 5.00% above today’s $66.84 share price. The 5 months bullish chart indicates low risk for the $145.82M company. The 1-year high was reported on Apr, 17 by If the $70.18 price target is reached, the company will be worth $7.29M more. The stock increased 13.67% or $8.04 during the last trading session, reaching $66.84. About 2,472 shares traded or 388.54% up from the average. PrimeEnergy Corporation (NASDAQ:PNRG) has declined 26.75% since April 17, 2017 and is downtrending. It has underperformed by 38.30% the S&P500.

Among 9 analysts covering Cardiovascular Systems (NASDAQ:CSII), 4 have Buy rating, 2 Sell and 3 Hold. Therefore 44% are positive. Cardiovascular Systems had 25 analyst reports since August 6, 2015 according to SRatingsIntel. Needham downgraded the shares of CSII in report on Friday, January 22 to “Underperform” rating. The stock of Cardiovascular Systems, Inc. (NASDAQ:CSII) earned “Buy” rating by Needham on Thursday, August 3. The company was downgraded on Thursday, September 3 by Zacks. The rating was maintained by Leerink Swann with “Outperform” on Thursday, February 8. On Friday, December 15 the stock rating was downgraded by Needham to “Hold”. The firm has “Neutral” rating by Bank of America given on Thursday, August 4. The company was maintained on Thursday, November 5 by Needham. Needham maintained Cardiovascular Systems, Inc. (NASDAQ:CSII) rating on Wednesday, August 30. Needham has “Buy” rating and $37.0 target. The company was upgraded on Friday, April 1 by Needham. The rating was maintained by Dougherty & Company on Thursday, October 8 with “Buy”.

Cardiovascular Systems, Inc., a medical technology company, develops, makes, and markets devices to treat vascular diseases in the United States. The company has market cap of $765.68 million. The firm offers peripheral arterial disease products, including Diamondback 360 Peripheral Orbital Atherectomy System , Diamondback 360 60cm Peripheral OAS, Diamondback 360 4 French 1.25 Peripheral OAS, Diamondback 360 1.50 Peripheral OAS, Diamondback 360 2.00 Peripheral OAS, and Stealth 360 Peripheral OAS, which are catheter platforms for treating a range of plaque types in leg arteries above and below the knee, including calcified plaque, as well as address various limitations associated with surgical, catheter, and pharmacological treatment alternatives. It currently has negative earnings. It also provides Diamondback 360 Coronary OAS, an atherectomy device for the treatment of calcified coronary arteries.

Cardiovascular Systems, Inc. (NASDAQ:CSII) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.


Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: